Mammoth hits the gas on therapeutic development with $195M in fresh funding
Doudna-founded biotech advancing in vivo CRISPR therapies with pair of new financings
Doudna-founded Mammoth is advancing its in vivo CRISPR therapies with a pair of new financings.
Sep 9, 2021 | 1:00 PM GMT
With a diagnostics platform